Novartis CEO Vas Narasimhan joins Anthropic board
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
The innovation is particularly suited for bone and cartilage repair
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Among his notable contributions is the development of the NAGI Stent, a widely adopted device for the drainage of pancreatic pseudocysts
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
The company allocated €56 million to research and development for next-generation line solutions
Subscribe To Our Newsletter & Stay Updated